Indian pharmaceutical firms are lagging behind their global counterparts across key performance parameters, including R&D intensity, proportion of PhD employees, and the number of patents and publications generated per billion USD of revenue, a report by Foundation for Advancing Science
Singapore, Dec 30 (ANI): A new study recently published by GlobalData suggests that the Philippines's newly enacted Universal Health Care (UHC) Act presents exciting opportunities for the Indian pharmaceutical industry.